{"id":544197,"date":"2018-01-26T14:21:19","date_gmt":"2018-01-26T13:21:19","guid":{"rendered":"https:\/\/hpsitaly.healthcare\/?p=544197"},"modified":"2022-03-26T15:41:02","modified_gmt":"2022-03-26T14:41:02","slug":"farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico","status":"publish","type":"post","link":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/","title":{"rendered":"Farmaci biosimilari nel futuro del trattamento del paziente ematologico"},"content":{"rendered":"<p><strong>AboutMedicine Highlights Anno V, N. 23, dicembre 2017<\/strong><\/p>\n<p><strong>Fabrizio Condorelli<\/strong><br \/>\n<em>Neurobiologia, Universit\u00e0 degli Studi del Piemonte Orientale A. Avogadro, Novara<br \/>\n<\/em><br \/>\n<strong>Matteo Della Porta<\/strong><br \/>\n<em>Ematologia, Cancer Center, IRCCS Humanitas Research Hospital &amp; Humanitas\u00a0University, Rozzano (Milano)<\/em><br \/>\n<strong>Filippo Gherlinzoni<\/strong><br \/>\n<em>Ematologia, Ospedale Ca\u2019 Foncello, Treviso<br \/>\n<\/em><br \/>\n<strong>Lorella Lombardozzi<\/strong><br \/>\n<em>Dirigente Area Politica del Farmaco, Regione Lazio<\/em><\/p>\n<p><strong>Ugo Trama<\/strong><br \/>\n<em>Farmacologia Sperimentale, Direzione Generale per la Tutela della Salute\u00a0<\/em><em>e il Coordinamento Sistema Sanitario Regionale, Napoli<\/em><\/p>\n<p><strong>Indice<\/strong><\/p>\n<ul>\n<li>Prefazione<\/li>\n<li>Introduzione<\/li>\n<li>Il farmaco biosimilare: una scelta consapevole<\/li>\n<li>Farmaci biosimilari in ematologia: ieri, oggi, domani<\/li>\n<li>Governance e accesso ai farmaci: come tradurre l\u2019utilizzo dei biosimilari in un\u2019opportunit\u00e0<\/li>\n<li>Bibliografia<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>AboutMedicine Highlights Anno V, N. 23, dicembre 2017 Fabrizio Condorelli <a href=\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":64199,"featured_media":542985,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[997],"tags":[],"class_list":["post-544197","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aboutmedicine-eng"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Farmaci biosimilari nel futuro del trattamento del paziente ematologico - HPS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Farmaci biosimilari nel futuro del trattamento del paziente ematologico - HPS\" \/>\n<meta property=\"og:description\" content=\"AboutMedicine Highlights Anno V, N. 23, dicembre 2017 Fabrizio Condorelli [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/\" \/>\n<meta property=\"og:site_name\" content=\"HPS\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-26T13:21:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-26T14:41:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hpsitaly.healthcare\/wp-content\/uploads\/2018\/01\/Cattura1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"619\" \/>\n\t<meta property=\"og:image:height\" content=\"885\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Eleonora Zaghis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eleonora Zaghis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/\",\"url\":\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/\",\"name\":\"Farmaci biosimilari nel futuro del trattamento del paziente ematologico - HPS\",\"isPartOf\":{\"@id\":\"https:\/\/hpsitaly.healthcare\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hpsitaly.healthcare\/wp-content\/uploads\/2018\/01\/Cattura1.png\",\"datePublished\":\"2018-01-26T13:21:19+00:00\",\"dateModified\":\"2022-03-26T14:41:02+00:00\",\"author\":{\"@id\":\"https:\/\/hpsitaly.healthcare\/#\/schema\/person\/ac9678267e7fdb22ca687b10475393bd\"},\"breadcrumb\":{\"@id\":\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#primaryimage\",\"url\":\"https:\/\/hpsitaly.healthcare\/wp-content\/uploads\/2018\/01\/Cattura1.png\",\"contentUrl\":\"https:\/\/hpsitaly.healthcare\/wp-content\/uploads\/2018\/01\/Cattura1.png\",\"width\":619,\"height\":885},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hpsitaly.healthcare\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farmaci biosimilari nel futuro del trattamento del paziente ematologico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hpsitaly.healthcare\/#website\",\"url\":\"https:\/\/hpsitaly.healthcare\/\",\"name\":\"HPS\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hpsitaly.healthcare\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/hpsitaly.healthcare\/#\/schema\/person\/ac9678267e7fdb22ca687b10475393bd\",\"name\":\"Eleonora Zaghis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hpsitaly.healthcare\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11db2ac5895a8a4b942ea1e775b297fb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11db2ac5895a8a4b942ea1e775b297fb?s=96&d=mm&r=g\",\"caption\":\"Eleonora Zaghis\"},\"url\":\"https:\/\/hpsitaly.healthcare\/en\/author\/eleonora-zaghis\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Farmaci biosimilari nel futuro del trattamento del paziente ematologico - HPS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/","og_locale":"en_US","og_type":"article","og_title":"Farmaci biosimilari nel futuro del trattamento del paziente ematologico - HPS","og_description":"AboutMedicine Highlights Anno V, N. 23, dicembre 2017 Fabrizio Condorelli [...]","og_url":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/","og_site_name":"HPS","article_published_time":"2018-01-26T13:21:19+00:00","article_modified_time":"2022-03-26T14:41:02+00:00","og_image":[{"width":619,"height":885,"url":"https:\/\/hpsitaly.healthcare\/wp-content\/uploads\/2018\/01\/Cattura1.png","type":"image\/png"}],"author":"Eleonora Zaghis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Eleonora Zaghis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/","url":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/","name":"Farmaci biosimilari nel futuro del trattamento del paziente ematologico - HPS","isPartOf":{"@id":"https:\/\/hpsitaly.healthcare\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#primaryimage"},"image":{"@id":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#primaryimage"},"thumbnailUrl":"https:\/\/hpsitaly.healthcare\/wp-content\/uploads\/2018\/01\/Cattura1.png","datePublished":"2018-01-26T13:21:19+00:00","dateModified":"2022-03-26T14:41:02+00:00","author":{"@id":"https:\/\/hpsitaly.healthcare\/#\/schema\/person\/ac9678267e7fdb22ca687b10475393bd"},"breadcrumb":{"@id":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#primaryimage","url":"https:\/\/hpsitaly.healthcare\/wp-content\/uploads\/2018\/01\/Cattura1.png","contentUrl":"https:\/\/hpsitaly.healthcare\/wp-content\/uploads\/2018\/01\/Cattura1.png","width":619,"height":885},{"@type":"BreadcrumbList","@id":"https:\/\/hpsitaly.healthcare\/en\/aboutmedicine-eng\/farmaci-biosimilari-nel-futuro-del-trattamento-del-paziente-ematologico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hpsitaly.healthcare\/en\/"},{"@type":"ListItem","position":2,"name":"Farmaci biosimilari nel futuro del trattamento del paziente ematologico"}]},{"@type":"WebSite","@id":"https:\/\/hpsitaly.healthcare\/#website","url":"https:\/\/hpsitaly.healthcare\/","name":"HPS","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hpsitaly.healthcare\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/hpsitaly.healthcare\/#\/schema\/person\/ac9678267e7fdb22ca687b10475393bd","name":"Eleonora Zaghis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hpsitaly.healthcare\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11db2ac5895a8a4b942ea1e775b297fb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11db2ac5895a8a4b942ea1e775b297fb?s=96&d=mm&r=g","caption":"Eleonora Zaghis"},"url":"https:\/\/hpsitaly.healthcare\/en\/author\/eleonora-zaghis\/"}]}},"_links":{"self":[{"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/posts\/544197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/users\/64199"}],"replies":[{"embeddable":true,"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/comments?post=544197"}],"version-history":[{"count":2,"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/posts\/544197\/revisions"}],"predecessor-version":[{"id":544199,"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/posts\/544197\/revisions\/544199"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/media\/542985"}],"wp:attachment":[{"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/media?parent=544197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/categories?post=544197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hpsitaly.healthcare\/en\/wp-json\/wp\/v2\/tags?post=544197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}